John N, Pathmanandavel S, Crumbaker M, Counter W, et al. (177)Lu-PSMA SPECT Quantitation at 6 Weeks (dose 2) Predicts Short Progression Free Survival for Patients Undergoing Lu PSMA I&T Therapy. J Nucl Med 2022 Sep 8. pii: jnumed.122.264677. doi: 10.2967/jnumed.122.264677.
PMID: 36215568